Articles by Suerie Moon
-
Tuesday
December 2
2014The Limits of Tiered Pricing (Part 2): Harvard’s Suerie Moon says policy tweaks could help ensure access to medicine
In Part 2 of a two-part post, Harvard’s Suerie Moon suggests four ways tiered-pricing policies for pharmaceuticals might be improved in the short-to-medium term, and also highlights some alternatives – including rewarding innovation.
- Categories
- Health Care
- Tags
- vaccines
-
Monday
December 1
2014NexThought Monday – The Limits of Tiered Pricing in Improving Access to Medicine: Harvard’s Suerie Moon looks at theoretical and empirical drawbacks
In the first of a two-part post, the author says tiered pricing is feasible when markets are separable and when the seller exerts significant power over pricing, such as when there is limited or no competition due to patent protection, data exclusivity or other barriers to market entry. But there are several reasons tiered pricing can be both ethically and practically problematic for pharmaceuticals.
- Categories
- Health Care